Scintimammography (SMM) in breast cancer patients

Journal of the Medical Association of Thailand

Volumn 82, Issue 3, 1999, Pages 242-249

  Mangkharak, Jiraporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Breast Cancer; Scintimammography; Technetium 99m MIBI; Thallium 201

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE METASTASIS; SCINTIMAMMOGRAPHY;

EID: 0032801149     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer. N Eng J Med 1992; 327: 319-28.
2. Tumor Registry, Siriraj Cancer Center, statistical report 1995.
3. Kopans DB. The positive predicitive value of mammography. AJR 1992; 158: 521-6.
4. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancer missed at the screening mammography. Radiology 1992; 184: 613-7.
5. Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993; 198: 297-301.
6. Serafini AN, Raskin MM, Zand CC, Watson DD. Radionuclide breast scanning in carcinoma of the breast. J Nucl Med 1974; 15: 1149-52.
7. Richman SD, Brodey PA, Frankel RS, et al. Breast scintigraphy with 99mTc-pertechnetate and Gallium citrate. J Nucl Med 1975; 16: 293-9.
8. Richman SD, Ingle JN, Levenson SM, et al. Usefulness of Gallium scintigraphy in primary and metastatic breast carcinoma. J Nucl Med 1975; 16: 996-1001.
9. Hahn P, Vikterlof KJ, Rydman KW, Blom O. The value of whole body bone scan in the preoperative assessment of carcinoma of the breast. Eur J Nucl Med 1979; 4: 207-10.
10. Hisada K, Tonami N, Miyamal T, et al. Clinical evaluation of tumor imaging with thallium-201 chloride. Radiology 1978; 129: 497-500.
11. Sluyser M, Hoefnagel C. Breast carcinomas detected by thallium-201 scintigraphy. Cancer 1988; 40: 161-8.
12. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34: 18-23.
13. Lee VW, Sax EJ, McAnemy DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993; 34: 2095-100.
14. Cimitan M, Volpe R, Candian E, et al. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur J Nucl Med 1995; 22: 1110-7.
15. Muller ST, Guth-Tougelides B, Creutzig H. Imaging of malignant tumors with Tc-99m MIBI SPECT [Abstract]. J Nucl Med 1987; 28(suppl): 562P.
16. Hassen IN, Sehweil A, Constantinidis C, et al. Uptake and kinetics of Tc-99m hexakis(2-methoxyisobutyl isonitrile) in benign and malignant lesions in the lungs. Clin Nucl Med 1989; 14: 333-40.
17. Aktolun C, Bayhan H, Kir M. Clinical experience with 99mTc -MIBI imaging in patients with malignant tumors: preliminary results and comparison with 201Tl. Clin Med Med 1992; 17: 171-6.
18. Mangkharak J, Pattanachak C, Podhisuwan K, Pleehachinda R. The evaluation of combined scintimammography and tumor markers in breast cancer patients. Anticanc Res 1997; 17: 1661-4.
19. Piccolo S, Lastoria S, Mainolfi C, et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995; 36: 718-24.
20. Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of Tl-201 uptake in tumors. Eur J Nucl Med 1989; 15: 376-9.
21. Cavelh PA, Chiu ML, Kronang JF, et al. Subcellular distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-21.
22. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1990; 31: 1166-7.
23. Chiu ML, Kronauge JF, Piwica-worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisohutylisonitrile) technetium (I) in cultured mouse fibroblast. J Nucl Med 1990; 31: 1646-53.
24. Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-84.
25. Piwnica-Worms D, Croop JM, Kramer RA, Kronauge JF. Tc-99m sestamibi in a transport substrate recognized by the multidrug resistent P-Glycoprotein [Abstract]. Proc Am Assoc Cancer Res 1993; 34: 309.
26. Kao CH, Wang SJ, Lui TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21: 432-6.
27. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicious of breast cancer. J Am Coll Surg 1994; 178: 491-7.
28. Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast carcinoma and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-65.
29. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-9.
30. Palmedo H, Schomberg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996, 37: 626-30.
31. Villanueva-Meyer J, Leonard Jr, Briscoe E, et al. Mammoscintigraphy with Technetium-99m sestamibi in suspected breast cancer. J Nucl Med 1996; 37: 926-30.
32. Waxman A, Ashok A, Kooba J, et al. The use of Tc99m-Methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast: comparison with T1201 (Tl)[Abstract]. J Nucl Med 1993; 34(suppl): 139P 557.
33. Mangkharak J, Podhisuwan K, Pleehachinda R Role of scintimammography (SMM) in the diagnosis and prognostic outcome of primary breast cancer [Abstract]. Kaku Igaku 1995; 32: 888.
34. Scopinaro F, Schillaei O, Scarpini M, et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21: 984-7.
35. Bradley G, Juranka PF, Ling V. Mechanism of multidrug resistance. Biochem Biophys Acta 1988; 848: 87-128.
36. Varrella P, Lastoria S, Vergara E, et al. Tc-99m MIBI scintimammography for monitoring tumor response in patients with advanced breast cancer [Abstract]. J Nucl Med 1995; 36: 193P-869.